Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07775404 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07775404 · ClinicalTrials.gov record · last posted 2026-08-27

A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus

Study acronym: Elecoglipron
StatusRecruiting
PhasePhase 3
Started2026-08-21
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose of this study is to evaluate the efficacy and safety of elecoglipron compared with placebo adjunct to diet and exercise for weight management, in adult participants living with obesity or overweight with or without T2DM.

Protocol amendment history 2 changes detected by DataLookout

2026-08-28
Recruitment opened
2026-08-28
Primary completion moved earlier: 2028-04-20 → 2027-06-04
Trial Details
NCT Number NCT07775404
Lead Sponsor AstraZeneca
Conditions Obesity, Overweight
Enrollment 351 participants
Start Date 2026-08-21
Primary Completion 2027-06-04 (estimated)
Study Completion 2028-04-20 (estimated)
Updated on ClinicalTrials.gov 2026-08-27